[New antimicrobial agent series XXVI: cefteram pivoxil].
Shimada
K
K
D001419:Bacteria / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy / Q000378:metabolism / Q000382:microbiology; D015281:Cefmenoxime / Q000031:analogs & derivatives*; D002511:Cephalosporins / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D014018:Tissue Distribution
D002511:Cephalosporins; C046817:cefteram pivoxil; D015281:Cefmenoxime